Welcome to our dedicated page for Agiliti news (Ticker: AGTI), a resource for investors and traders seeking the latest updates and insights on Agiliti stock.
Agiliti, Inc. (NYSE: AGTI) is a leading healthcare technology management and service solutions provider in the United States, serving over 10,000 national, regional, and local acute care and alternate site providers. With a team of 3,000 dedicated equipment management experts, Agiliti is committed to optimizing clinical outcomes and improving economic efficiency for its customers. The company’s comprehensive suite of services includes medical equipment management, clinical engineering services, and on-site managed services, which help healthcare providers reduce costs, increase operational efficiency, and deliver optimal patient outcomes.
In recent financial highlights, Agiliti reported a revenue growth of 6.2% for Q2 2023, reaching $291 million. Despite a net loss of $4 million, the company maintained a positive outlook on business visibility and predictability, forecasting annual revenues between $1.16 billion and $1.19 billion. Agiliti has adjusted its EBITDA guidance to $260-$270 million for 2023, reflecting the impact of contract onboarding and business mix changes. The company’s strategic initiatives include a $50 million share repurchase program, indicating confidence in its long-term strategy.
Agiliti’s leadership also saw changes with the return of Tom Leonard as CEO in October 2023, following the departure of Tom Boehning. Under Leonard’s leadership, Agiliti aims to continue its growth trajectory and strengthen its position in the healthcare technology management sector. Key announcements include the company’s agreement to be acquired by Thomas H. Lee Partners, L.P. for $10.00 per share, valuing Agiliti at approximately $2.5 billion, a transaction expected to close in the first half of 2024. This move is poised to further enhance Agiliti’s operational capabilities and market reach.
Agiliti’s annual and quarterly financial results reflect consistent performance, with notable earnings and revenue growth despite industry challenges. The company’s commitment to innovation and client-centric service delivery underscores its role as an essential partner in the U.S. healthcare system.
Agiliti announced the retirement of
Agiliti Inc. (NYSE: AGTI) reported its Q3 2022 financial results, revealing a 3% revenue growth to $271 million. However, net income fell $7.7 million year-over-year, totaling $2 million, and diluted EPS decreased by $0.06 to $0.01. Adjusted EBITDA also declined by 18.9% to $66.5 million. Despite a 12.2% revenue increase for the nine months ended September 30, 2022, the company revised its full-year guidance to $1.11 - $1.12 billion in revenue and $290-300 million in adjusted EBITDA, reflecting a cautious outlook.
Agiliti Inc. (NYSE: AGTI) will release its third quarter results on November 10, 2022, after market close. A conference call will follow at 5 p.m. Eastern Time, where investors can join via phone or webcast. Agiliti provides essential services to the U.S. healthcare industry, supporting over 9,000 healthcare providers with solutions aimed at enhancing efficiency and patient outcomes. For more information, access details for the call and its replay are available through Agiliti's Investor Relations website.
Agiliti Inc. (AGTI) reported a 9% increase in revenue for Q2 2022, totaling $274 million. Net income rose to $5 million, reflecting a $10.2 million year-over-year increase. However, adjusted EBITDA decreased by 10.4% to $69.6 million. The company maintained its 2022 financial guidance with revenue expectations of $1.16 - $1.19 billion and adjusted EBITDA of $305 - $315 million, anticipating results at the lower end of the range. CEO Tom Leonard cited temporary challenges affecting financial results but expressed confidence in the company's ongoing business strength.
Agiliti Inc. (NYSE: AGTI) will announce its second quarter results on August 9, 2022, after market close, followed by a conference call at 5 p.m. Eastern Time. Interested parties can listen via phone at 1-877-407-0792 or internationally at 1-201-689-8263. A replay will be available two hours post-call until August 16, 2022. Agiliti provides essential services to the U.S. healthcare sector, managing medical equipment for over 9,000 providers, enhancing cost efficiency and patient outcomes.
Agiliti Inc. (NYSE: AGTI) reported Q1 2022 financial results, with revenue growth of 25.2% to $294.4 million and a net income of $19.9 million, up 108.2% from the prior year. Diluted earnings per share increased to $0.14, a rise of $0.05 year-over-year. Adjusted EBITDA reached $89.2 million, a 3.4% increase. The company reaffirmed its 2022 outlook, forecasting revenue between $1,160 - $1,190 million and adjusted earnings per share of $0.89 - $0.94. The total debt stands at $1,121 million with a net leverage ratio of 3.2x.
Agiliti Inc. (NYSE: AGTI) announced its participation in upcoming investor conferences. The BofA Securities Healthcare Conference will occur on May 11, 2022, with a fireside chat at 4:40 PM local time in Las Vegas. Additionally, Agiliti will participate in the UBS Global Healthcare Conference on May 24, 2022, with a chat at 4:15 PM local time in New York. Investors can listen to webcasts via the company’s Investor Relations website. Agiliti provides essential services to the U.S. healthcare sector, serving over 9,000 providers.
Agiliti Inc. (NYSE: AGTI) will release its first quarter results after market close on May 10, 2022. A conference call is scheduled for 5 p.m. Eastern Time, accessible via phone and webcast. The company provides essential services to the U.S. healthcare sector, serving over 9,000 healthcare providers and delivering solutions to enhance cost-efficiency and patient outcomes. The replay of the call will be available until May 17, 2022.
Agiliti Inc. (NYSE: AGTI) will participate in the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022. The company is set to host 1x1 investor meetings and a fireside chat at 3 p.m. Eastern Time on the same day. Investors can access a live webcast of the fireside chat via the Investor Relations section on Agiliti's website. With over 80 years in the industry, Agiliti provides essential services to the U.S. healthcare sector, enhancing efficiency and supporting patient outcomes for over 9,000 healthcare providers nationwide.
Agiliti Inc. (NYSE: AGTI) reported a 36% revenue growth in Q4 2021, reaching $290 million, with net income of $10 million. Full-year revenue increased by 34% to $1.04 billion, driven by a strong performance in healthcare technology services. Adjusted EBITDA for Q4 grew 18% to $85 million, with a full-year total of $331 million, a 41% increase. The company expects 2022 revenue between $1.16 - $1.19 billion and adjusted EBITDA of $305-315 million. A new one-year agreement with the U.S. HHS for ventilator maintenance was also established, consolidating existing contracts.
FAQ
What is the current stock price of Agiliti (AGTI)?
What is the market cap of Agiliti (AGTI)?
What services does Agiliti, Inc. provide?
What is Agiliti's recent financial performance?
Who is the CEO of Agiliti, Inc.?
What are Agiliti's future financial projections?
Has Agiliti announced any significant corporate actions?
What is the purpose of Agiliti's share repurchase program?
Where can I find Agiliti's financial reports and conference call details?
What challenges is Agiliti facing in the current market?
How does Agiliti support the healthcare industry?
What is the status of Agiliti's acquisition by Thomas H. Lee Partners?
